Active-energy-ray-curable composition, active-energy-ray-curable ink, composition stored container, two-dimensional or three-dimensional image forming method, two-dimensional or three-dimensional image forming apparatus, and processed product

US10604666B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10604666-B2
Application numberUS-201615351974-A
CountryUS
Kind codeB2
Filing dateNov 15, 2016
Priority dateNov 16, 2015
Publication dateMar 31, 2020
Grant dateMar 31, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An active-energy-ray-curable composition including: a magenta pigment; a polymerizable compound; and a pigment adsorption component, an amount of the pigment adsorption component (A 0 ) adsorbed onto 100 mg of the magenta pigment being from 10 mg through 60 mg.

First claim

Opening claim text (preview).

What is claimed is: 1. An active-energy-ray-curable composition, comprising: a magenta pigment; a polymerizable compound; and a pigment adsorption component, wherein: an amount of the pigment adsorption component (A 0 ) adsorbed onto 100 mg of the magenta pigment is from 10 mg through 60 mg; the magenta pigment is a surface-treated magenta pigment that was surface treated with an acid; and a percentage of change in the amount of the pigment adsorption component (ΔA) as determined by Formula (1) below is within ±20%: Δ A (%)=( A−A 0 )/ A 0 ×100  (1), where: A is an amount of the pigment adsorption component adsorbed onto the 100 mg of the magenta pigment after the active-energy-ray-curable composition is left to stand at 70° C. for 14 days. 2. The active-energy-ray-curable composition according to claim 1 , wherein the amount of the pigment adsorption component (A 0 ) absorbed onto the 100 mg of the magenta pigment is from 15 mg through 50 mg. 3. The active-energy-ray-curable composition according to claim 1 , wherein the percentage of change in the amount of the pigment adsorption component (ΔA) as determined by the Formula (1) is within ±18%. 4. The active-energy-ray-curable composition according to claim 1 , wherein: a 50% cumulative volume particle diameter of the active-energy-ray-curable composition is 80 nm or more but 180 nm or less; and a distribution width of a particle size distribution of the active-energy-ray-curable composition as determined by Formula (2) below is 90 nm or less: Distribution width of particle size distribution=(84% cumulative volume particle diameter−16% cumulative volume particle diameter)/2  (2). 5. The active-energy-ray-curable composition according to claim 1 , wherein the magenta pigment includes a quinacridone pigment. 6. The active-energy-ray-curable composition according to claim 1 , wherein: the pigment adsorption component is a dispersant polymer including an amino group; and the dispersant polymer has an amine value of 10 mg KOH/g or more but 30 mg KOH/g or less. 7. An active-energy-ray-curable ink, comprising an active-energy-ray-curable composition, wherein: the active-energy-ray-curable composition includes: a magenta pigment, a polymerizable compound, and a pigment adsorption component; an amount of the pigment adsorption component (A 0 ) adsorbed onto 100 mg of the magenta pigment is from 10 mg through 60 mg; and a percentage of change in the amount of the pigment adsorption component (ΔA) as determined by Formula (1) below is within ±20%: Δ A (%)=( A−A 0 )/ A 0 ×100  (1), where: A is an amount of the pigment adsorption component adsorbed onto the 100 mg of the magenta pigment after the active-energy-ray-curable composition is left to stand at 70° C. for 14 days. 8. An inkjet discharging device, comprising the active-energy-ray-curable ink according to claim 7 . 9. A composition stored container, comprising: the active-energy-ray-curable composition according to claim 1 ; and a container containing the active-energy-ray-curable composition. 10. A two-dimensional or three-dimensional image forming apparatus, comprising: a storing part including the active-energy-ray-curable ink according to claim 7 ; and an irradiator configured to irradiate the active-energy-ray-curable ink with active energy rays. 11. The two-dimensional or three-dimensional image forming apparatus according to claim 10 , further comprising: an ejecting unit configured to eject the active-energy-ray-curable ink by an inkjet recording system. 12. A two-dimensional or three-dimensional image forming method, comprising: irradiating the active-energy-ray-curable composition according to claim 1 with active energy rays. 13. The two-dimensional or three-dimensional image forming method according to claim 12 , further comprising: ejecting the active-energy-ray-curable composition by an inkjet recording system. 14. A two-dimensional or three-dimensional image, wherein the two-dimensional or three-dimensional image is obtained by irradiating the active-energy-ray-curable composition according to claim 1 with active energy rays, and curing the active-energy-ray-curable composition. 15. A structure, comprising: a substrate; and the two-dimensional or three-dimensional image according to claim 14 on the substrate. 16. A processed product, wherein the processed product is obtained by subjecting the two-dimensional or three-dimensional image according to claim 14 to a drawing process. 17. A processed product, wherein the processed product is obtained by subjecting the structure according to claim 15 to a drawing process. 18. A curable composition, comprising: a magenta pigment; a polymerizable compound; and a pigment adsorption component, wherein: an amount of the pigment adsorption component (A 0 ) adsorbed onto 100 mg of the magenta pigment is from 10 mg through 60 mg; the magenta pigment is a surface-treated magenta pigment that was surface treated with an acid; and a percentage of change in the amount of the pigment adsorption component (ΔA) as determined by Formula (1) below is within ±20%: Δ A (%)=( A−A 0 )/ A 0 ×100  (1), where: A is an amount of the pigment adsorption component adsorbed onto the 100 mg of the magenta pigment after the active-energy-ray-curable composition is left to stand at 70° C. for 14 days. 19. The curable composition according to claim 18 , wherein the curable composition can be cured without irradiating the curable composition with active energy rays. 20. The active-energy-ray-curable ink according to claim 7 , wherein a static surface tension of the active-energy-ray-curable ink at 25° C. is 20 nN/m or more and 40 nN/m or less.

Assignees

Inventors

Classifications

  • of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen · CPC title

  • Pigment inks · CPC title

  • characterised by the pigment dispersant · CPC title

  • C09D11/101Primary

    Inks specially adapted for printing processes involving curing by wave energy or particle radiation, e.g. with UV-curing following the printing · CPC title

  • by radiation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10604666B2 cover?
An active-energy-ray-curable composition including: a magenta pigment; a polymerizable compound; and a pigment adsorption component, an amount of the pigment adsorption component (A 0 ) adsorbed onto 100 mg of the magenta pigment being from 10 mg through 60 mg.
Who is the assignee on this patent?
Hirade Tomohiro, Asami Tsuyoshi, Ricoh Co Ltd
What technology area does this patent fall under?
Primary CPC classification C09D11/101. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).